InsiderTrades

Form 4 for RGEN REPLIGEN CORP

Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-16 · accession 0000899243-22-028997 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-08-17 2022-08-16 RGEN Snodgres Jon CFO S - Sale+OE $252.86 -6,698 36.9K -15% -$1.69M
DM 2022-08-17 2022-08-16 RGEN Snodgres Jon CFO M - OptEx $117.37 +4,017 41.2K +11% +$471.5K
DM 2022-08-17 2022-08-16 RGEN Snodgres Jon CFO M - OptEx $0.00 +4,017 1,524 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-08-16 S D 2,400 $253.16 34,506 D — —
2 Common Common Stock 2022-08-16 S D 4,298 $252.70 36,906 D — — (F1) $252.70 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.16 to $253.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
3 Common Common Stock 2022-08-16 M A 3,047 $86.10 40,234 D — —
4 Common Common Stock 2022-08-16 M A 970 $215.58 41,204 D — —
5 Derivative Stock Option (Right to Buy) 2022-08-16 M A 970 $0.00 1,940 D $215.58 · — to 2031-02-24 970 Common Stock (F3) Shares vest and become exercisable as follows: 970 shares on 2/24/2023 and 970 shares on 2/24/2024.
6 Derivative Stock Option (Right to Buy) 2022-08-16 M A 3,047 $0.00 1,524 D $86.10 · — to 2030-02-27 3,047 Common Stock (F2) 1,524 shares vest and become exercisable on 2/27/2023.